Analysts note celebrity attention has boosted demand for these drugs, though resulting shortages have led their manufacturer, Novo Nordisk, to scale back some marketing activities
As these treatments become more popular, theyre changing how the industry approaches chronic diseasebringing both fresh opportunities but also new challenges
Safety across all trials The side effect profile is consistent across studies
*Correspondence: Antonella Sgarbossa, [email protected] This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Our practice recognizes the importance of supporting individuals frequently exposed to high-risk environments, such as healthcare workers or those in crowded settings
Always consult your doctor before taking a new medication